ID   PRDX1_RAT               Reviewed;         199 AA.
AC   Q63716;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 183.
DE   RecName: Full=Peroxiredoxin-1;
DE            EC=1.11.1.24 {ECO:0000250|UniProtKB:Q06830};
DE   AltName: Full=HBP23;
DE   AltName: Full=Heme-binding 23 kDa protein;
DE   AltName: Full=Thioredoxin peroxidase 2;
DE   AltName: Full=Thioredoxin-dependent peroxide reductase 2;
DE   AltName: Full=Thioredoxin-dependent peroxiredoxin 1 {ECO:0000305};
GN   Name=Prdx1; Synonyms=Tdpx2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7577926; DOI=10.1021/bi00041a017;
RA   Iwahara S., Satoh H., Song D.-X., Webb J., Burlingame A.L., Nagae Y.,
RA   Mueller-Eberhard U.;
RT   "Purification, characterization, and cloning of a heme-binding protein (23
RT   kDa) in rat liver cytosol.";
RL   Biochemistry 34:13398-13406(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver, and Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 17-35 AND 111-190, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Diao W., Kang S.U.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN OXIDIZED FORM, AND DISULFIDE
RP   BONDS.
RX   PubMed=10535922; DOI=10.1073/pnas.96.22.12333;
RA   Hirotsu S., Abe Y., Okada K., Nagahara N., Hori H., Nishino T.,
RA   Hakoshima T.;
RT   "Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding
RT   protein 23 kDa/proliferation-associated gene product.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:12333-12338(1999).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS), DISULFIDE BONDS, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=17974571; DOI=10.1074/jbc.m705753200;
RA   Matsumura T., Okamoto K., Iwahara S., Hori H., Takahashi Y., Nishino T.,
RA   Abe Y.;
RT   "Dimer-oligomer interconversion of wild-type and mutant rat 2-Cys
RT   peroxiredoxin: disulfide formation at dimer-dimer interfaces is not
RT   essential for decamerization.";
RL   J. Biol. Chem. 283:284-293(2008).
CC   -!- FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of
CC       hydrogen peroxide and organic hydroperoxides to water and alcohols,
CC       respectively. Plays a role in cell protection against oxidative stress
CC       by detoxifying peroxides and as sensor of hydrogen peroxide-mediated
CC       signaling events. Might participate in the signaling cascades of growth
CC       factors and tumor necrosis factor-alpha by regulating the intracellular
CC       concentrations of H(2)O(2) (By similarity). Reduces an intramolecular
CC       disulfide bond in GDPD5 that gates the ability to GDPD5 to drive
CC       postmitotic motor neuron differentiation (By similarity).
CC       {ECO:0000250|UniProtKB:P0CB50, ECO:0000250|UniProtKB:Q06830}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + a hydroperoxide = [thioredoxin]-
CC         disulfide + an alcohol + H2O; Xref=Rhea:RHEA:62620, Rhea:RHEA-
CC         COMP:10698, Rhea:RHEA-COMP:10700, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:29950, ChEBI:CHEBI:30879, ChEBI:CHEBI:35924,
CC         ChEBI:CHEBI:50058; EC=1.11.1.24;
CC         Evidence={ECO:0000250|UniProtKB:Q06830};
CC   -!- SUBUNIT: Homodimer; disulfide-linked, upon oxidation (PubMed:10535922).
CC       5 homodimers assemble to form a ring-like decamer (PubMed:17974571).
CC       Interacts with GDPD5; forms a mixed-disulfide with GDPD5 (By
CC       similarity). Interacts with SESN1 and SESN2 (By similarity). Interacts
CC       with FAM107A (By similarity). {ECO:0000250|UniProtKB:P0CB50,
CC       ECO:0000250|UniProtKB:Q06830, ECO:0000269|PubMed:10535922,
CC       ECO:0000269|PubMed:17974571}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q06830}.
CC   -!- PTM: Phosphorylated on Thr-90 during the M-phase, which leads to a
CC       decrease in enzymatic activity. {ECO:0000250|UniProtKB:Q06830}.
CC   -!- MISCELLANEOUS: The active site is a conserved redox-active cysteine
CC       residue, the peroxidatic cysteine (C(P)), which makes the nucleophilic
CC       attack on the peroxide substrate. The peroxide oxidizes the C(P)-SH to
CC       cysteine sulfenic acid (C(P)-SOH), which then reacts with another
CC       cysteine residue, the resolving cysteine (C(R)), to form a disulfide
CC       bridge. The disulfide is subsequently reduced by an appropriate
CC       electron donor to complete the catalytic cycle. In this typical 2-Cys
CC       peroxiredoxin, C(R) is provided by the other dimeric subunit to form an
CC       intersubunit disulfide. The disulfide is subsequently reduced by
CC       thioredoxin. {ECO:0000305|PubMed:10535922}.
CC   -!- SIMILARITY: Belongs to the peroxiredoxin family. AhpC/Prx1 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D30035; BAA06275.1; -; mRNA.
DR   EMBL; BC058450; AAH58450.1; -; mRNA.
DR   EMBL; BC088118; AAH88118.1; -; mRNA.
DR   PIR; I52425; I52425.
DR   RefSeq; NP_476455.1; NM_057114.1.
DR   PDB; 1QQ2; X-ray; 2.60 A; A/B=1-199.
DR   PDB; 2Z9S; X-ray; 2.90 A; A/B/C/D/E/F/G/H/I/J=1-199.
DR   PDBsum; 1QQ2; -.
DR   PDBsum; 2Z9S; -.
DR   AlphaFoldDB; Q63716; -.
DR   SMR; Q63716; -.
DR   BioGRID; 250701; 8.
DR   IntAct; Q63716; 7.
DR   MINT; Q63716; -.
DR   STRING; 10116.ENSRNOP00000023132; -.
DR   PeroxiBase; 4508; Rno2CysPrx01.
DR   iPTMnet; Q63716; -.
DR   PhosphoSitePlus; Q63716; -.
DR   SwissPalm; Q63716; -.
DR   jPOST; Q63716; -.
DR   PaxDb; 10116-ENSRNOP00000023132; -.
DR   Ensembl; ENSRNOT00000023132.6; ENSRNOP00000023132.2; ENSRNOG00000017194.6.
DR   Ensembl; ENSRNOT00055022725; ENSRNOP00055018456; ENSRNOG00055013251.
DR   Ensembl; ENSRNOT00060050497; ENSRNOP00060042039; ENSRNOG00060029088.
DR   Ensembl; ENSRNOT00065027783; ENSRNOP00065021904; ENSRNOG00065016670.
DR   GeneID; 117254; -.
DR   KEGG; rno:117254; -.
DR   UCSC; RGD:620039; rat.
DR   AGR; RGD:620039; -.
DR   CTD; 5052; -.
DR   RGD; 620039; Prdx1.
DR   eggNOG; KOG0852; Eukaryota.
DR   GeneTree; ENSGT00940000154277; -.
DR   HOGENOM; CLU_042529_21_1_1; -.
DR   InParanoid; Q63716; -.
DR   OMA; FWYPKDF; -.
DR   OrthoDB; 47465at2759; -.
DR   PhylomeDB; Q63716; -.
DR   TreeFam; TF105181; -.
DR   BRENDA; 1.11.1.24; 5301.
DR   Reactome; R-RNO-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-RNO-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-RNO-9818027; NFE2L2 regulating anti-oxidant/detoxification enzymes.
DR   EvolutionaryTrace; Q63716; -.
DR   PRO; PR:Q63716; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000017194; Expressed in duodenum and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0000791; C:euchromatin; IDA:RGD.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005782; C:peroxisomal matrix; IDA:RGD.
DR   GO; GO:0020037; F:heme binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0004601; F:peroxidase activity; ISO:RGD.
DR   GO; GO:0051920; F:peroxiredoxin activity; IDA:RGD.
DR   GO; GO:0008379; F:thioredoxin peroxidase activity; ISO:RGD.
DR   GO; GO:0007249; P:canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0045454; P:cell redox homeostasis; IBA:GO_Central.
DR   GO; GO:0034101; P:erythrocyte homeostasis; ISO:RGD.
DR   GO; GO:0048144; P:fibroblast proliferation; ISO:RGD.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; ISO:RGD.
DR   GO; GO:0045321; P:leukocyte activation; IBA:GO_Central.
DR   GO; GO:0030101; P:natural killer cell activation; ISO:RGD.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:1901222; P:regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0032872; P:regulation of stress-activated MAPK cascade; ISO:RGD.
DR   GO; GO:0019430; P:removal of superoxide radicals; ISO:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:RGD.
DR   GO; GO:0000302; P:response to reactive oxygen species; ISO:RGD.
DR   CDD; cd03015; PRX_Typ2cys; 1.
DR   DisProt; DP02793; -.
DR   Gene3D; 3.40.30.10; Glutaredoxin; 1.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR050217; Peroxiredoxin.
DR   InterPro; IPR024706; Peroxiredoxin_AhpC-typ.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR10681:SF111; PEROXIREDOXIN-1; 1.
DR   PANTHER; PTHR10681; THIOREDOXIN PEROXIDASE; 1.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   PIRSF; PIRSF000239; AHPC; 1.
DR   SUPFAM; SSF52833; Thioredoxin-like; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antioxidant; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; Isopeptide bond; Oxidoreductase;
KW   Peroxidase; Phosphoprotein; Redox-active center; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   CHAIN           2..199
FT                   /note="Peroxiredoxin-1"
FT                   /id="PRO_0000135078"
FT   DOMAIN          6..165
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   ACT_SITE        52
FT                   /note="Cysteine sulfenic acid (-SOH) intermediate"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   MOD_RES         7
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   MOD_RES         16
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   MOD_RES         27
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   MOD_RES         35
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   MOD_RES         35
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35700"
FT   MOD_RES         90
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   MOD_RES         136
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35700"
FT   DISULFID        52
FT                   /note="Interchain (with C-173); in linked form"
FT                   /evidence="ECO:0000269|PubMed:10535922,
FT                   ECO:0000269|PubMed:17974571, ECO:0007744|PDB:1QQ2"
FT   DISULFID        173
FT                   /note="Interchain (with C-52); in linked form"
FT                   /evidence="ECO:0000269|PubMed:10535922,
FT                   ECO:0000269|PubMed:17974571, ECO:0007744|PDB:1QQ2"
FT   CROSSLNK        7
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   CROSSLNK        185
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:Q06830"
FT   STRAND          16..20
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          26..30
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   HELIX           31..34
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          37..43
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          50..52
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   HELIX           57..61
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   HELIX           63..68
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          71..78
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   HELIX           81..88
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   HELIX           92..94
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   HELIX           111..115
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          121..124
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          128..133
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          137..145
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   HELIX           153..168
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   STRAND          170..172
FT                   /evidence="ECO:0007829|PDB:1QQ2"
FT   TURN            188..191
FT                   /evidence="ECO:0007829|PDB:2Z9S"
FT   HELIX           192..195
FT                   /evidence="ECO:0007829|PDB:2Z9S"
SQ   SEQUENCE   199 AA;  22109 MW;  BDF2D4ABA8A776DA CRC64;
     MSSGNAKIGH PAPSFKATAV MPDGQFKDIS LSDYKGKYVV FFFYPLDFTF VCPTEIIAFS
     DRAEEFKKLN CQVIGASVDS HFCHLAWINT PKKQGGLGPM NIPLVSDPKR TIAQDYGVLK
     ADEGISFRGL FIIDDKGILR QITINDLPVG RSVDEILRLV QAFQFTDKHG EVCPAGWKPG
     SDTIKPDVNK SKEYFSKQK
//
